Clinical and Molecular Characteristics of Histiocytic Disorders
Conditions: Histiocytic Disorder Interventions: Other: Non-Interventional Study Sponsors: Mayo Clinic Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
Biomarkers for Diagnostic, Prognostic and of Response to Treatment in Adult Langerhans Cell Histiocytosis
Conditions: Histiocytosis, Langerhans-Cell Interventions: Other: Blood sampling; Other: Biopsy; Other: Blood sampling Sponsors: Assistance Publique - H ôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2024 Category: Research Source Type: clinical trials
Mirdametinib in Histiocytic Disorders
Conditions: Langerhans Cell Histiocytosis (LCH); Juvenile Xanthogranuloma (JXG); Rosai-Dorfman Disease (RDD); Histiocytic Disorders Interventions: Drug: Mirdametinib Sponsors: Children ' s Hospital Medical Center, Cincinnati Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 1, 2023 Category: Research Source Type: clinical trials
Oral Prednisone in Treating LCH of Bone in Childhood and Adolescence
Conditions: Langerhans Cell Histiocytosis of Bone Interventions: Drug: Prednisone Sponsors: Shanghai Changzheng Hospital; First Affiliated Hospital of Zhejiang University; Peking University Third Hospital; National Sun Yat-sen University; Beijing Children ' s Hospital; Henan Cancer Hospital; Tianjin Hospital; First Affiliated Hospital, Sun Yat-Sen University; Second Hospital of Jilin University; Peking University People ' s Hospital; Jinling hospital Nanjing, Jiangsu, China; The First Affiliated Hospital of Nanchang University; The Third Affiliated Hospital of Southern Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2023 Category: Research Source Type: clinical trials
National Registry of Rare Kidney Diseases
Conditions: Adenine Phosphoribosyltransferase Deficiency; AH Amyloidosis; AHL Amyloidosis; AL Amyloidosis; Alport Syndrome; Atypical Hemolytic Uremic Syndrome; Autoimmune Distal Renal Tubular Acidosis; Autosomal Recessive Proximal Renal Tubular Acidosis; Autosomal Recessive Distal Renal Tubular Acidosis; Autosomal Dominant Polycystic Kidney Disease; Autosomal Recessive Polycystic Kidney Disease; Bartter Syndrome; BK Nephropathy; C3 Glomerulopathy With Monoclonal Gammopathy; C3 Glomerulopathy; Calciphylaxis; Crystalglobulinaemia; Crystal-storing Histiocytosis; Cystinosis; Cystinuria; Dense Deposit Disease; Dent Disease; Den...
Source: ClinicalTrials.gov - October 4, 2023 Category: Research Source Type: clinical trials
To Evaluate the Efficacy, Safety, and PK Characteristics of FCN-159 in Pediatric Patients With Refractory/Recurrent LCH
Conditions: Langerhans Cell Histiocytosis; LCH Intervention: Drug: FCN-159 Sponsor: Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 18, 2023 Category: Research Source Type: clinical trials
Histiocytic Disorder Follow-up Study
Conditions: Histiocytosis; Langerhans Cell Histiocytosis; Erdheim-Chester Disease; Rosai Dorfman Disease; Xanthogranuloma; Malignant Histiocytoses Intervention: Sponsor: University of Alabama at Birmingham Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials
